Khaki, A.R. Li, A. Diamantopoulos, L.N. Miller, N.J. Carril-Ajuria, L. Castellano, D. De Kouchkovsky, I. Koshkin, V. Park, J. Alva, A. Bilen, M.A. Stewart, T. Santos, V. Agarwal, N. Jain, J. Zakharia, Y. Morales-Barrera, R. Devitt, M. Nelson, A. Hoimes, C.J. Shreck, E. Gartrell, B.A. Sankin, A. Tripathi, A. Zakopoulou, R. Bamias, A. Rodriguez-Vida, A. Drakaki, A. Liu, S. Kumar, V. Lythgoe, M.P. Pinato, D.J. Murgic, J. Fröbe, A. Joshi, M. Isaacsson Velho, P. Hahn, N. Alonso Buznego, L. Duran, I. Moses, M. Barata, P. Galsky, M.D. Sonpavde, G. Yu, E.Y. Shankaran, V. Lyman, G.H. Grivas, P., A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors, European urology oncology, (4), 464-472, 2021, NLM (Medline),